CVS vs RVTY: fair value comparison
CVS Health Corporation and Revvity, Inc. · Updated 2026-08-31
Both currently screen as overvalued on TickrTrends' Forward Fair Value model. Within Healthcare, CVS currently sits closer to the top of our discount ranking. RVTY carries the stronger quality grade.
| CVS | RVTY | |
|---|---|---|
| Verdict | Overvalued | Overvalued |
| Last price | $93.06 | $128.80 |
| 12-month range | $72.49–$105.37 | $86.68–$115.22 |
| Sector rank | #88 of 113 Healthcare | #91 of 113 Healthcare |
| Quality grade | F | A |
| Momentum grade | — | B |
| Leverage | Moderate | Low |
| Margin trend | Stable | Contracting |
| Revenue growth | Modest | Modest |
| RSI zone | Oversold | Overbought |
| DCF cross-check | Overvalued | Overvalued |
| 52-week position | The upper-middle quarter | The top quarter |
Full single-stock breakdowns: CVS fair value analysis · RVTY fair value analysis